formaldehyde has been researched along with fk 409 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozaki-Taguchi, N; Yamamoto, T | 2 |
| Amano, T; Deyama, S; Kaneda, K; Minami, M; Mori, S; Sugano, Y; Yoshioka, M | 1 |
3 other study(ies) available for formaldehyde and fk 409
| Article | Year |
|---|---|
The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Formaldehyde; Inflammation; Injections, Subcutaneous; Male; Morphine; Nitric Oxide; Nitro Compounds; Pain; Rats; Rats, Sprague-Dawley | 1998 |
Involvement of nitric oxide in peripheral antinociception mediated by kappa- and delta-opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzoates; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Formaldehyde; Imidazoles; Male; Nitric Oxide; Nitro Compounds; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa | 1998 |
Activation of the NMDA receptor-neuronal nitric oxide synthase pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain.
Topics: Animals; Conditioning, Operant; Cyclic N-Oxides; Disease Models, Animal; Excitatory Postsynaptic Potentials; Formaldehyde; Free Radical Scavengers; Hydroxylamines; Imidazoles; Male; Membrane Potentials; Neurons; Nitric Oxide Synthase Type I; Nitro Compounds; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Septal Nuclei; Signal Transduction | 2017 |